Bronchiectasis is an irreversible pathologic dilatation or ectasia of the bronchi due to repeated airway infection and inflammation.
It enhances susceptibility to bronchial infection and increases inflammatory reaction which causes further lung damage.
Classic symptoms of of bronchiectasis are cough with chronic sputum production along with recurring infective exacerbations and hemoptysis.
Drug Information

Indication: Nasopharyngeal, lower resp tract, skin & soft tissue infections.

Indication: Infections caused by clarithromycin-sensitive pathogens: Nasopharynx (eg, tonsillitis, pharyngitis), paranasal...

Indication: Upper resp tract infections eg, strep pharyngitis/tonsillitis, acute maxillary sinusitis; lower resp tract inf...

Indication: Short-term treatment for upper & lower resp tract, GUT, skin & soft tissue, bone & joint infection...

Indication: Upper & lower resp tract (including ENT), skin & soft tissue, GUT, bone & joint infections; intra-...

Indication: Short-term treatment for upper & lower resp tract, skin & soft tissue, bone & joint & dental i...

Indication: Upper & lower urinary tract, resp & genital tract, GIT, skin & wound infections. Bacterial infecti...

Indication: Pre- & post-op infections associated w/ surgery, trauma or gynaecology; septicaemia & other infections...

Indication: Otitis media, lower & upper resp tract infections, UTI, skin & skin structure infections, sinusitis, g...

Duro-Tuss Expectorant
bromhexine hydrochloride + pholcodine

Indication: Excessive cough & effective expectoration in bronchitis & other resp conditions associated w/ mucoid s...

4  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 28 May 2020
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
Roshini Claire Anthony, 08 May 2020

At present, there are no definitive treatments for COVID-19. More than 300 clinical trials are ongoing in the search for a cure. Some of the treatments being tested were previously used, with varying levels of efficacy, in the treatment of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS).

Roshini Claire Anthony, 24 Apr 2020

The gap in overall life expectancy between people with HIV (PWH) and those without HIV has narrowed over time, particularly among optimally treated PWH. However, PWH still have fewer comorbidity-free years than those without HIV, according to a study presented at CROI 2020.